financetom
Business
financetom
/
Business
/
Fortis Healthcare says can go for massive expansion, so looking at targets to acquire
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fortis Healthcare says can go for massive expansion, so looking at targets to acquire
Sep 13, 2022 5:32 AM

Fortis Healthcare is looking at potential targets to acquire as it is in "a potition for massive expansion", Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare, told CNBC-TV18.

Share Market Live

NSE

“We have a good brownfield expansion plan where we are adding almost 25 percent further capacity or around 1,500-1,700 beds. And, for that, the funds are tied up," said Raghuvanshi.

"Beyond that, we have the capacity to do further mergers, but we would go strategically — first in the areas we already have presence and then if there are any opportunities where a perform cluster in an attractive location and at an attractive valuation is available."

The firm plans to go for accelerated growth but is waiting for a legal issue to get over. Raghuvanshi said the judgement on the open offer for Fortis Healthcare, which will allow Malaysia’s IHH Healthcare Berhad to take a controlling stake in India’s second-largest hospital chain can be announced anytime this month.

In 2018 the Securities and Exchange Board of India (Sebi) approved IHH Healthcare to launch an open offer for shareholders of Fortis, asking them to tender their shares at Rs 170 apiece. Sebi approved the proposal for the open offer worth Rs 3350 crore in December 2018.

Later, Japanese pharmaceutical company Daiichi Sankyo challenged IHH's proposed acquisition of Fortis in an effort to hold the Fortis founders accountable for an arbitration award of Rs 3,600 crore ($500 million) resulting from a fraud claim. In December 2018, the SC halted the IHH-Fortis agreement.

Also read: Indian markets poised to go up a lot, says Julius Baer's Mark Matthews

Having taken a 31 percent controlling position in Fortis in 2018, the IHH group was required to make an open bid to purchase a further 26 percent of the company's shares from the market. Due to ongoing court processes, the open offer has not been implemented.

“IIH is absolutely committed to Fortis and India as a market and they have reportedly said that Fortis is going to be their main vehicle for expansion, so IIH is committed to Fortis and we are looking forward to having this legal thing behind us very soon,” said Raghuvanshi.

Watch the accompaning video for the full interview.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

(Edited by : Nishtha Pandey)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ANI news agency files suit against Netflix for using its content in Indian hijack drama
ANI news agency files suit against Netflix for using its content in Indian hijack drama
Sep 9, 2024
NEW DELHI, Sept 9 (Reuters) - India's ANI news agency has filed a suit in court against Netflix Inc ( NFLX ) and producers of an Indian series about a plane hijack, asking for four episodes to be taken down as they used ANI content without licence, ANI's lawyer told Reuters on Monday. Reuters has a minority stake in the...
Confluent Insider Sold Shares Worth $4,647,675, According to a Recent SEC Filing
Confluent Insider Sold Shares Worth $4,647,675, According to a Recent SEC Filing
Sep 9, 2024
03:16 AM EDT, 09/09/2024 (MT Newswires) -- Edward Jay Kreps, Director, Chief Executive Officer, on September 04, 2024, sold 232,500 shares in Confluent (CFLT) for $4,647,675. Following the Form 4 filing with the SEC, Kreps has control over a total of 452,488 shares of the company, with 452,488 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1699838/000141588924023055/xslF345X05/form4-09062024_100943.xml Price: 19.90, Change: +0.30, Percent Change:...
Apogee Therapeutics Insider Sold Shares Worth $1,904,841, According to a Recent SEC Filing
Apogee Therapeutics Insider Sold Shares Worth $1,904,841, According to a Recent SEC Filing
Sep 9, 2024
03:15 AM EDT, 09/09/2024 (MT Newswires) -- Michael Thomas Henderson, Director, Chief Executive Officer, on September 04, 2024, sold 40,000 shares in Apogee Therapeutics ( APGE ) for $1,904,841. Following the Form 4 filing with the SEC, Henderson has control over a total of 1,394,487 shares of the company, with 1,394,487 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1974640/000110465924097866/xslF345X05/tm2423502-1_4seq1.xml ...
MSP Recovery Seeks New Agreements to Boost Revenue
MSP Recovery Seeks New Agreements to Boost Revenue
Sep 9, 2024
03:51 AM EDT, 09/09/2024 (MT Newswires) -- MSP Recovery ( LIFW ) said Sunday it has launched an initiative to secure new agreements with health plans, providers, insurers, and attorneys. The company said the initiative is expected to generate revenue through fees charged on savings from unnecessary Medicare secondary payments. Additionally, the company's largest creditor, Virage Capital Partners, has agreed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved